Pricing and pricing strategy
Pricing and pricing strategy for the launch of Advanced Therapy Medicinal Products (ATMPs), taking into account a positive G-BA decision, is an important step to ensure that the product is commercially successful while meeting the requirements of the healthcare system.
- Development costs
- Production costs
- Market position
- Competition
- Positive opinion of national stakeholders in the health care system (G-BA, Swissmedic, AGES etc.)
In pricing and pricing strategy, manufacturers of ATMPs should carefully consider all of the above factors to ensure that the price is competitive but also sufficient to cover development costs and production costs. A carefully aligned pricing and reimbursement system is critical to the commercial success of ATMPs and to patient access to innovative therapies.
